Article
Serotonin transporter promoter polymorphism in African Americans : allele frequencies and implications for treatment.
American journal of pharmacogenomics : genomics-related research in drug development and clinical practice - 1 Jan 2003
Lotrich Francis E, Pollock Bruce G, Ferrell Robert E
Abstract excerpt
BACKGROUND: Americans of African ancestry are less likely to receive a selective serotonin reuptake inhibitor (SSRI) for treatment of major depressive disorder than Americans of European ancestry. A functional insertion/deletion polymorphism in the promoter of the serotonin transporter (5-HTT) gene SLC6A4 has been shown to modulate SLC6A4 transcription, affecting response to SSRIs. Several studies in populations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
